← Leaderboards
David E Olson
University Of California At Davis
$5,171,634
Attributed
$5,171,634
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,171,634 · 3
By mechanism
R01$3,963,375 · 2
R35$1,208,259 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Aiming Yu$12,077,836
- Ethan Marsh Fenton$42,895
Others in their field
Other Emerging Leaders on “Property”
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Susan Abushakra · Alzheon, Inc.$47,265,244
- John Hobbs · Suny At Stony Brook$42,194,917
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,689,447
- Eric C Palm · Florida State University$35,115,872
Research focus
PropertyAutopsyScaffoldSynapsesMental DepressionStructureNeuronsPlayStructure-Activity RelationshipSafetyDendritic SpinesAnimal ModelNeuropsychiatric DisorderSmall MoleculeNeuronal PlasticityFunctional DisorderHallucinogensHuman ImagingPrefrontal CortexAtrophicAnalogPost-Traumatic Stress DisordersPharmaceutical PreparationsIboga
Grant awards (16)
High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction$541,161
R01 · FY2025 · DA · contact PI
Chemical and Molecular Tools for Modulating GPCR Function$316,440
R35 · FY2025 · GM · contact PI
High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction$540,503
R01 · FY2024 · DA · contact PI
Chemical and Molecular Tools for Modulating GPCR Function$316,281
R35 · FY2024 · GM · contact PI
Supplement: Chemical and Molecular Tools for Modulating GPCR Function$199,971
R35 · FY2024 · GM · contact PI
High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction$538,861
R01 · FY2023 · DA · contact PI
Chemical and Molecular Tools for Modulating GPCR Function$375,567
R35 · FY2023 · GM · contact PI
High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction$552,154
R01 · FY2022 · DA · contact PI
Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$278,056
R01 · FY2022 · GM · contact PI
Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$118,342
R01 · FY2022 · GM · contact PI
Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$281,324
R01 · FY2021 · GM · contact PI
Administrative supplement: Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$118,342
R01 · FY2021 · GM · contact PI
Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$284,294
R01 · FY2020 · GM · contact PI
Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$286,995
R01 · FY2019 · GM · contact PI
Administrative Supplement to Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$133,893
R01 · FY2019 · GM · contact PI
Design, Synthesis, and Evaluation of Neural Plasticity-Promoting Analogs of Iboga and Ergoline Alkaloids$289,450
R01 · FY2018 · GM · contact PI